Intraosseous Infusion Devices Market Size & Growth Forecast 2026–2035, By Segments (Type, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growoth Outlook
Intraosseous Infusion Devices Market size was valued at USD 1.02 Billion in 2025 and is projected to grow at a 6.3% CAGR from 2026 to 2035, surpassing USD 1.88 Billion by 2035. The industry revenue for 2026 is estimated at USD 1.08 billion.
Get more details on this report
Request Free Sample ReportIntraosseous Infusion Devices Market Intelligence Snapshot
Regional Market Dynamics
- North America captured 43.78% of the market in 2025, supported by established emergency care infrastructure, routine intraosseous access use, and well-equipped hospital and ambulance networks.
- Asia Pacific is forecast to grow at a 7.12% CAGR as emergency care capacity expands, trauma services improve, and healthcare systems increasingly adopt advanced critical care protocols and rapid vascular access devices.
Segment Momentum
- Manual IO Needles accounted for 52.36% of the market in 2025, supported by broad clinical familiarity, simple deployment, dependable performance without power requirements, and seamless integration into emergency care protocols.
- Ambulatory Surgical Centers are expanding rapidly as they strengthen emergency preparedness and adopt intraosseous access devices that support rapid intervention, workflow continuity, and efficient response to unexpected procedural complications.
Market Expansion Drivers
- Rising emergency care cases and trauma incidence increasing demand for rapid vascular access solutions.
- Growing geriatric population and cardiovascular disease burden driving emergency intervention needs.
- Advancements in emergency medical device technology improving intraosseous access safety and efficiency.
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Top players in the intraosseous infusion devices market include Teleflex Incorporated (United States), Becton, Dickinson and Company (United States), Cook Medical LLC (United States), SAM Medical Products (United States), Cardinal Health, Inc. (United States), Argon Medical Devices, Inc. (United States), Aero Healthcare Pty Ltd. (Australia), BIOPSYBELL S.R.L. (Italy), Pyng Medical Corporation (Canada), PerSys Medical, Inc. (United States).Regional and Segment Outlook
North AmericaMarket Growth Drivers and Industry Trends
As emergency departments, ambulance services, and trauma centers handle a higher volume of critically injured and hemodynamically unstable patients, speed of access becomes a decisive factor in treatment protocols. This is directly encouraging market growth for the intraosseous infusion devices market because clinicians often face failed or delayed peripheral IV placement during shock, severe blood loss, burns, or cardiac arrest, where seconds influence stabilization outcomes. In practice, rising trauma and emergency caseloads are prompting hospitals and prehospital care systems to standardize rapid vascular access pathways, increase stocking of intraosseous kits on crash carts and ambulances, and train frontline staff to use these devices earlier in resuscitation sequences rather than reserving them only as a last resort.
Growing geriatric population and cardiovascular disease burden driving emergency intervention needs
Older adults with cardiovascular disease are more likely to present with cardiac arrest, acute circulatory compromise, stroke-related emergencies, and other time-sensitive conditions in which conventional venous access can be difficult to obtain. That pattern is reinforcing market demand for the intraosseous infusion devices market, as emergency teams need dependable access for fluids and medications when fragile veins, poor perfusion, or complex comorbidities slow IV cannulation. The practical effect is stronger adoption in hospital emergency care, critical care transport, and code response settings, where clinicians increasingly view intraosseous access as a reliable intervention for elderly high-acuity patients who require immediate stabilization.
Advancements in emergency medical device technology improving intraosseous access safety and efficiency
Product improvements are influencing market adoption by making intraosseous insertion faster, more consistent, and easier to integrate into high-pressure emergency workflows. In the intraosseous infusion devices market, advances in powered insertion systems, needle design, placement reliability, and user-oriented ergonomics reduce procedural hesitation among clinicians who may have previously relied on conventional IV attempts for too long. This is strengthening market development by broadening usability beyond highly specialized operators, supporting training uptake, and encouraging procurement decisions from hospitals and EMS providers that prioritize devices capable of delivering rapid access with fewer insertion challenges during critical interventions.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising emergency care cases and trauma incidence increasing demand for rapid vascular access solutions | 2.00% | Moderate | North America | High | Near Term |
| Growing geriatric population and cardiovascular disease burden driving emergency intervention needs | 1.80% | High | North America, Europe | High | Mid Term |
| Advancements in emergency medical device technology improving intraosseous access safety and efficiency | 1.60% | Moderate | Asia Pacific, North America | Medium | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America held the leading position in 2025, accounting for a 43.78% share of the intraosseous infusion devices market. This leadership is supported by the region’s established emergency and critical care infrastructure, where intraosseous access is routinely used when rapid vascular access is difficult in trauma, cardiac arrest, and pre-hospital settings. Broad clinical familiarity, structured emergency response systems, and the presence of hospitals and ambulance networks equipped to adopt specialized access devices help sustain purchasing volumes and consistent procedural use across acute care environments.
Asia Pacific is projected to expand at a 7.12% CAGR over the forecast period, with growth in the intraosseous infusion devices market being fueled by the ongoing expansion of emergency care capacity and wider adoption of advanced critical care practices. As healthcare systems across the region strengthen trauma response, emergency medicine, and hospital-based acute care services, demand rises for devices that enable fast access in time-sensitive situations. Adoption is also being accelerated by improving clinical capabilities and greater integration of modern emergency treatment protocols into frontline care settings.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Response ReadinessGermany emphasizes dependable intraosseous access devices for emergency departments and intensive care settings. Hospitals in Germany focus on clinically validated products that support standardized emergency response protocols and practitioner confidence.
France 🇫🇷
Hospital Emergency SupportFrance is incorporating intraosseous infusion devices into hospital emergency care and advanced life support practices. Clinical teams in France seek devices that simplify emergency procedures while maintaining consistent patient safety standards.
Italy 🇮🇹
Critical Access PreparednessItaly is reinforcing emergency medical capabilities with greater availability of intraosseous infusion technologies. Healthcare institutions in Italy focus on reliable devices that support rapid intervention during trauma, resuscitation, and critical care scenarios.
Japan 🇯🇵
Acute Care PrecisionJapan is strengthening emergency preparedness through advanced infusion technologies for critical care environments. Medical facilities in Japan increasingly value intraosseous devices that offer ease of use, procedural accuracy, and reliable performance.
South Korea 🇰🇷
Trauma Care EnhancementSouth Korea is expanding the use of intraosseous infusion devices in emergency and trauma care services. Healthcare providers in South Korea prioritize portable systems that enable rapid vascular access while supporting efficient clinical workflows.
United States 🇺🇸
Emergency Care IntegrationThe U.S. continues expanding intraosseous infusion device adoption across emergency medicine, military healthcare, and prehospital care. Healthcare providers in the U.S. prioritize rapid vascular access solutions that improve treatment efficiency during critical interventions.
Segment Leadership and Growth Trends
Intraosseous Infusion Devices Market Share (%), Type, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportManual IO Needles held the strongest position in the intraosseous infusion devices market in 2025, accounting for a 52.36% share. Their continued leadership is largely tied to broad clinical familiarity, straightforward deployment in emergency settings, and dependable use without reliance on power sources or device charging. In urgent access situations, providers often prioritize tools that are readily available, simple to store, and easy to integrate into established protocols, which helps Manual IO Needles maintain their strong share across routine emergency and critical care use in the intraosseous infusion devices market.
Battery Powered Driver is emerging as the fastest-growing segment in the intraosseous infusion devices market because healthcare settings are placing greater value on speed, consistency, and ease of insertion during high-pressure procedures. Compared with manual alternatives, battery-assisted systems support more standardized access in demanding clinical scenarios, which is driving adoption where workflow efficiency and rapid vascular access are increasingly important. This momentum is especially supported by the practical need to reduce procedural variability and improve operator confidence in time-sensitive care environments.
End-use Segment Analysis: Hospitals and Clinics (Largest Segment) vs Ambulatory Surgical Centers (Fastest-Growing Segment)
Hospitals and Clinics represented the largest end-use segment in the intraosseous infusion devices market in 2025, with a 57.65% share. Their leadership reflects the concentration of emergency care, trauma response, and critical treatment pathways in these settings, where intraosseous access is most likely to be required when conventional vascular access is delayed or difficult. The ability of hospitals and clinics to manage a high volume of acute cases, supported by trained staff and established emergency protocols, continues to sustain their dominant share in the intraosseous infusion devices market.
Ambulatory Surgical Centers are the fastest-growing end-use segment in the intraosseous infusion devices market as these facilities continue to strengthen their preparedness for urgent procedural complications and rapid intervention needs. Growth is being supported by the increasing emphasis on maintaining efficient emergency access capabilities in outpatient surgical environments, where response speed and procedural continuity are essential. Relative to more traditional care settings, ambulatory centers are gaining momentum as they expand their clinical readiness standards and adopt devices that support quick action in unexpected escalation scenarios.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Type | Manual IO Needles, Battery Powered Driver, Impact Driven Devices | Manual IO Needles | Battery Powered Driver |
| End-use | Hospitals and Clinics, Ambulatory Surgical Centers, Others | Hospitals and Clinics | Ambulatory Surgical Centers |
Competitive Landscape and Market Positioning
1. Teleflex Incorporated (United States)
2. Becton Dickinson and Company (United States)
3. Cook Medical LLC (United States)
4. SAM Medical Products (United States)
5. Cardinal Health Inc. (United States)
6. Argon Medical Devices Inc. (United States)
7. Aero Healthcare Pty Ltd. (Australia)
8. BIOPSYBELL S.R.L. (Italy)
9. Pyng Medical Corporation (Canada)
10. PerSys Medical Inc. (United States)
The intraosseous infusion devices market is evolving with increasing focus on rapid emergency access solutions. Innovation emphasizes improving insertion speed and reliability under critical conditions. The intraosseous infusion devices market is also shaped by demand for advanced trauma care equipment. Enhanced device design is improving clinical responsiveness in emergency settings.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Teleflex Incorporated | Jun-23 | Teleflex received U.S. FDA 510(k) clearance in June 2023 for its Arrow EZ-IO intraosseous needle with MR conditional labeling. The device is a core component of the EZ-IO vascular access system and is designed to enable rapid, precise intraosseous insertion in emergency care settings. |
| Safeguard Medical | Jan-22 | Safeguard Medical launched the NIO+ Adult intraosseous device in January 2022. The ultra-compact system is engineered for durability and rapid vascular access in high-stress emergency environments, strengthening pre-hospital and trauma care capabilities. |
| SAM Medical | Mar-20 | SAM Medical launched the SAM IO Intraosseous Access System in March 2020. The manually operated device supports rapid vascular access for hospital, pre-hospital, military, and civilian emergency care applications, expanding options for critical fluid and drug delivery. |
| PAVmed | Mar-22 | PAVmed reported successful first-in-human implantations of its PortIO Intraosseous Infusion System in March 2022. The early clinical study involved multiple patients under IRB approval, evaluating long-term intraosseous access performance in a controlled clinical setting. |
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Intraosseous Infusion Devices Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Intraosseous Infusion Devices Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow big is the intraosseous infusion devices market?
What is the anticipated CAGR of the intraosseous infusion devices industry?
How are rising emergency and trauma cases influencing adoption of intraosseous infusion devices?
What role are technological improvements playing in the wider clinical adoption of intraosseous access systems?
Why do Manual IO Needles hold the largest share of the intraosseous infusion devices market?
Why are Ambulatory Surgical Centers the fastest-growing end-use segment in the intraosseous infusion devices market?
Why is North America the largest market for intraosseous infusion devices?
What factors are accelerating market growth in Asia Pacific?
Who are the major participants shaping the intraosseous infusion devices landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization